Months Later: Cramer’s Dividend Stock Check-In Sparks Debate
Nine months after Jim Cramer touted Energy Transfer as a top dividend pick for retirees, the stock has delivered on i...
Using Coupons For Grocery Cash Back
Discover how using coupons for grocery cash back can help you save more on your grocery purchases. Start using coupons today!
22,116 articlesBoring Beats Brilliant: Utilities ETF Survives Recession
A utilities-focused ETF has delivered defensive resilience through several recessions this century, as AI demand and ...
Rocket Still Red. Here: 4 Reasons to Buy RKLB Stock
Rocket Lab isn’t profitable yet, but the space company shows four clear catalysts for investors. Here are practical r...
Roblox Down 2026: Will the Pain End Soon for Investors
Roblox shares slid 9% today, pushing the year-to-date drop to roughly 42%. The move came amid broad risk-off trading ...
Kathy Griffin Says She’s Rewriting Her Financial Playbook
When opportunities wobble, money follows. This piece breaks down how public perception, gigs, and branding affect inc...
Cramer Says Oracle “Going Down,” Here’s What He’d Buy
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
Naya Capital Adds Masimo: A Deep Dive Into the Move
A notable fund adds Masimo stock, signaling confidence in noninvasive monitoring tech. This analysis breaks down the ...
Million Exit From This Cybersecurity Stock Signals Shift
A sharp, near-$99 million exit from this cybersecurity stock has analysts buzzing about a possible shift in investor ...
This Fund Sold Million: Clean Energy ETF Rally Still Bullish
A notable move in a clean energy ETF raised questions: does a big sale signal trouble or discipline in a fast-growing...
Ramsey Advice Shifts Small-Biz Debt Strategy Amid Rates
A 41-year-old digital-marketing firm owner faced a $575,162 debt pile alongside a $620,000 home. The Ramsey Show weig...
Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status